Biyopsikososyal Yaklaşım Eşliğinde Sekonder Hipertansiyon Çözümlemesi
Year 2022,
Volume: 1 Issue: 1, 18 - 19, 06.06.2022
Selma Türker
,
Cüneyt Ardıç
Abstract
Primer hiperaldosteronizm sekonder hipertansiyonun yaygın görülen sebeplerinden birisi olup, tanı konulup medikal veya cerrahi yolla tedavi edilmesi oldukça önemlidir. Bu olgu sunumunda; 15 yıldır hipertansiyon tanısı olup medikal tedaviye rağmen tansiyon takipleri yüksek seyreden, laboratuvar tetkiklerinde metabolik alkaloz ve hipopotasemi saptanan primer hiperaldosteronizm olgusu anlatılmıştır.
References
- 1. Weiner ID. Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism. Semin Nephrol. 2013 May;33(3):265-76. doi: 10.1016/j.semnephrol.2013.04.007. PMID: 23953804; PMCID: PMC3748390.
- 2. CONN JW. Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med. 1955 Jan;45(1):3-17. PMID: 13233623.
- 3. Weiner ID. Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism. Semin Nephrol. 2013 May;33(3):265-76. doi: 10.1016/j.semnephrol.2013.04.007. PMID: 23953804; PMCID: PMC3748390.
- 4. TEMD Obezite, Lipit Metabolizması, Hipertansiyon Çalışma Grubu, Hipertansiyon Tanı ve Tedavi Klavuzu, Türkiye Endokrinoloji ve Metabolizma Derneği, 2019
- 5. Mulatero P, Bertello C, Verhovez A, Rossato D, Giraudo G, Mengozzi G, Limerutti G, Avenatti E, Tizzani D, Veglio F. Differential diagnosis of primary aldosteronism subtypes. Curr Hypertens Rep. 2009 Jun;11(3):217-23. doi: 10.1007/s11906-009-0038-1. PMID: 19442332.
- 6. Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, Sechi LA. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med. 2008 Jan 14;168(1):80-5. doi: 10.1001/archinternmed.2007.33. PMID: 18195199.
7. Ateş E, Set T, Turkiye Klinikleri J Fam Med-Special Topics 2017;8(2):93-5
Analysis of Secondary Hypertension Accompanied by a Biopsychosocial Approach
Year 2022,
Volume: 1 Issue: 1, 18 - 19, 06.06.2022
Selma Türker
,
Cüneyt Ardıç
References
- 1. Weiner ID. Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism. Semin Nephrol. 2013 May;33(3):265-76. doi: 10.1016/j.semnephrol.2013.04.007. PMID: 23953804; PMCID: PMC3748390.
- 2. CONN JW. Presidential address. I. Painting background. II. Primary aldosteronism, a new clinical syndrome. J Lab Clin Med. 1955 Jan;45(1):3-17. PMID: 13233623.
- 3. Weiner ID. Endocrine and hypertensive disorders of potassium regulation: primary aldosteronism. Semin Nephrol. 2013 May;33(3):265-76. doi: 10.1016/j.semnephrol.2013.04.007. PMID: 23953804; PMCID: PMC3748390.
- 4. TEMD Obezite, Lipit Metabolizması, Hipertansiyon Çalışma Grubu, Hipertansiyon Tanı ve Tedavi Klavuzu, Türkiye Endokrinoloji ve Metabolizma Derneği, 2019
- 5. Mulatero P, Bertello C, Verhovez A, Rossato D, Giraudo G, Mengozzi G, Limerutti G, Avenatti E, Tizzani D, Veglio F. Differential diagnosis of primary aldosteronism subtypes. Curr Hypertens Rep. 2009 Jun;11(3):217-23. doi: 10.1007/s11906-009-0038-1. PMID: 19442332.
- 6. Catena C, Colussi G, Nadalini E, Chiuch A, Baroselli S, Lapenna R, Sechi LA. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med. 2008 Jan 14;168(1):80-5. doi: 10.1001/archinternmed.2007.33. PMID: 18195199.
7. Ateş E, Set T, Turkiye Klinikleri J Fam Med-Special Topics 2017;8(2):93-5